ATE399207T1 - Lipoxygenaseproteine und für diese kodierende polynukleotide - Google Patents

Lipoxygenaseproteine und für diese kodierende polynukleotide

Info

Publication number
ATE399207T1
ATE399207T1 AT00923241T AT00923241T ATE399207T1 AT E399207 T1 ATE399207 T1 AT E399207T1 AT 00923241 T AT00923241 T AT 00923241T AT 00923241 T AT00923241 T AT 00923241T AT E399207 T1 ATE399207 T1 AT E399207T1
Authority
AT
Austria
Prior art keywords
lipoxygenase
polynucleotides encoding
proteins
lipoxygenase proteins
novel
Prior art date
Application number
AT00923241T
Other languages
English (en)
Inventor
C Turner
Brian Zambrowicz
Michael Nehls
Glenn Friedrich
Arthur Sands
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE399207T1 publication Critical patent/ATE399207T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00923241T 1999-04-12 2000-04-12 Lipoxygenaseproteine und für diese kodierende polynukleotide ATE399207T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12881799P 1999-04-12 1999-04-12
US15045499P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
ATE399207T1 true ATE399207T1 (de) 2008-07-15

Family

ID=26826972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923241T ATE399207T1 (de) 1999-04-12 2000-04-12 Lipoxygenaseproteine und für diese kodierende polynukleotide

Country Status (9)

Country Link
US (4) US6582957B1 (de)
EP (1) EP1171609B1 (de)
JP (1) JP2002541810A (de)
AT (1) ATE399207T1 (de)
AU (1) AU777409B2 (de)
CA (1) CA2365916A1 (de)
DE (1) DE60039290D1 (de)
DK (1) DK1171609T3 (de)
WO (1) WO2000061765A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090323A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 46638, a putative family member of human lipoxygenase
JP2005538679A (ja) * 2001-10-24 2005-12-22 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア サン ディエゴ アテローム性動脈硬化症に寄与する主要遺伝子としての５−リポキシゲナーゼの同定
US20030080191A1 (en) * 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
WO2003052681A1 (en) * 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
US20050131733A1 (en) * 2001-12-17 2005-06-16 Allen Lubow Sealable individual bar coded packets
AR045260A1 (es) 2003-08-12 2005-10-19 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos
AU2004268625B2 (en) 2003-08-27 2011-03-31 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
EP1673087B1 (de) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy-substituierte imidazochinoline
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
EP1687307B1 (de) 2003-11-25 2016-01-06 3M Innovative Properties Company Substituierte imidazoringsysteme und verfahren
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US20050267145A1 (en) * 2004-05-28 2005-12-01 Merrill Bryon A Treatment for lung cancer
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
EP1831226B1 (de) 2004-12-30 2012-08-08 3M Innovative Properties Company Chirale tetracyklische verbindungen, die interferon biosyntheze induzieren
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
EP1863814A1 (de) 2005-04-01 2007-12-12 Coley Pharmaceutical Group, Inc. 1-substitutierte pyrazolo-(3,4-c)-ringverbindungen als cytokinbiosynthese-modulatoren für die behandlung viraler infektionen und neoplastischer erkrankungen
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
EP2154153A1 (de) * 2008-08-08 2010-02-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mutantes Alpha-Synuklein und Verwendungsverfahren dafür
WO2011153121A2 (en) * 2010-06-01 2011-12-08 Board Of Supervisors Of Louisiana State University. And Agricultural And Mechanical College A soluble and stable human 5-lipoxygenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02453A (ja) * 1987-12-28 1990-01-05 Japan Tobacco Inc ヒト５−リポキシゲナーゼポリペプチドをコードする遺伝子
CA2077461C (en) * 1992-08-28 2000-02-15 Jerry L. Nadler Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway
WO1999013111A1 (en) * 1997-09-11 1999-03-18 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US6204037B1 (en) * 1998-04-16 2001-03-20 Vanderbilt University Lipoxygenase proteins and nucleic acids

Also Published As

Publication number Publication date
WO2000061765A2 (en) 2000-10-19
US20030172391A1 (en) 2003-09-11
US7144730B2 (en) 2006-12-05
EP1171609B1 (de) 2008-06-25
DK1171609T3 (da) 2008-08-11
WO2000061765A3 (en) 2001-02-22
US20080125578A1 (en) 2008-05-29
DE60039290D1 (de) 2008-08-07
US20070136832A1 (en) 2007-06-14
AU777409B2 (en) 2004-10-14
EP1171609A2 (de) 2002-01-16
JP2002541810A (ja) 2002-12-10
US6582957B1 (en) 2003-06-24
AU4340000A (en) 2000-11-14
CA2365916A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
ATE399207T1 (de) Lipoxygenaseproteine und für diese kodierende polynukleotide
Miyata et al. Primary structure of hemorrhagic protein, HR2a, isolated from the venom of Trimeresurus flavoviridis
DE60042122D1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
NO20065528L (no) Forbindelser som fremmer vevsvekst.
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE69932599D1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
WO2001046260A3 (en) Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof
EA200400812A1 (ru) Секретируемый белок
BR9710919A (pt) Proteina purificada sr-p70
ATE315092T1 (de) Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen
EA200501711A1 (ru) Семейство секретируемых белков
GB0210783D0 (en) Anti-microbial polypeptides
ATE338126T1 (de) Dna-sequenz und rekombinante herstellung eines graminaen-allergens
EA200300642A1 (ru) Связанные с шизофренией ген и белок потенциал-зависимого воротного ионного канала
ATE327987T1 (de) Methylthiophencarboxanilide
HUP9802289A2 (hu) Limfocita specifikus interferon szabályozó faktor (LSIRF) polipeptideket kódoló gének
DE60039708D1 (de) Menschliches chordin und polynukleotiden die dafür kodieren
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
DE60139458D1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties